Schedule 13D ownership disclosure

SYNTA PHARMACEUTICALS CORP

Security class unavailable · CUSIP: 87162T206

Event date: 2015-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-15-005236
Form type
SC 13D/A
Filer
CxSynta LLC
CIK
CIK 1388171
Filed
Jul 07, 2015
Reporting period
Jun 30, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub